These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30894497)

  • 81. Protein phosphatase 5 mediates corticosteroid insensitivity in airway smooth muscle in patients with severe asthma.
    Chachi L; Abbasian M; Gavrila A; Alzahrani A; Tliba O; Bradding P; Wardlaw AJ; Brightling C; Amrani Y
    Allergy; 2017 Jan; 72(1):126-136. PubMed ID: 27501780
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.
    Kleiman A; Tuckermann JP
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):98-108. PubMed ID: 17587493
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Pathogenesis of steroid-resistant asthma and the influence of vitamin D].
    Yan YX; Li YN
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jul; 21(7):724-729. PubMed ID: 31315776
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Glucocorticoid efficacy in asthma: is improved tissue remodeling upstream of anti-inflammation.
    Freishtat RJ; Nagaraju K; Jusko W; Hoffman EP
    J Investig Med; 2010 Jan; 58(1):19-22. PubMed ID: 19730133
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inotodiol, an antiasthmatic agent with efficacy and safety, preferentially impairs membrane-proximal signaling for mast cell activation.
    Liu Y; Naskar R; Acharya S; Ba Vinh L; Kim JH; Lee JY; Kim YH; Kang JS; Hwang I
    Int Immunopharmacol; 2023 Apr; 117():109854. PubMed ID: 36812673
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Marine-Derived Compounds for the Potential Treatment of Glucocorticoid Resistance in Severe Asthma.
    Ghiciuc CM; Vicovan AG; Stafie CS; Antoniu SA; Postolache P
    Mar Drugs; 2021 Oct; 19(11):. PubMed ID: 34822457
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Immune Repertoire and Advancements in Nanotherapeutics for the Impediment of Severe Steroid Resistant Asthma (SSR).
    Beeraka NM; Zhou R; Wang X; Vikram P R H; Kumar TP; Liu J; Greeshma MV; Mandal SP; Gurupadayya BM; Fan R
    Int J Nanomedicine; 2022; 17():2121-2138. PubMed ID: 35592101
    [TBL] [Abstract][Full Text] [Related]  

  • 89. New drugs targeting Th2 lymphocytes in asthma.
    Caramori G; Groneberg D; Ito K; Casolari P; Adcock IM; Papi A
    J Occup Med Toxicol; 2008 Feb; 3 Suppl 1(Suppl 1):S6. PubMed ID: 18315837
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The Role of Glucocorticoids in Inflammatory Diseases.
    Reichardt SD; Amouret A; Muzzi C; Vettorazzi S; Tuckermann JP; Lühder F; Reichardt HM
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831143
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Genomic and non-genomic effects of glucocorticoids in respiratory diseases.
    Lee ZY; Tran T
    Adv Pharmacol; 2023; 98():1-30. PubMed ID: 37524484
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Development and validation of a novel bioassay to determine glucocorticoid sensitivity.
    Williams EL; Stimpson ML; Collins PL; Enki DG; Sinha A; Lee RW; Dhanda AD
    Biomark Res; 2016; 4():26. PubMed ID: 27999674
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Elucidating novel disease mechanisms in severe asthma.
    Kim RY; Rae B; Neal R; Donovan C; Pinkerton J; Balachandran L; Starkey MR; Knight DA; Horvat JC; Hansbro PM
    Clin Transl Immunology; 2016 Jul; 5(7):e91. PubMed ID: 27525064
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Establishment method and experimental application of the mouse model of severe asthma].
    Xie LX; Feng GZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):514-518. PubMed ID: 35527468
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Erratum: Discovery of a highly potent glucocorticoid for asthma treatment.
    He Y; Shi J; Yi W; Ren X; Gao X; Li J; Wu N; Weaver K; Xie Q; Khoo SK; Yang T; Huang X; Melcher K; Xu HE
    Cell Discov; 2016; 2():15051. PubMed ID: 27462447
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Combined treatment with SB203580 and dexamethasone suppresses non-typeable Haemophilus influenzae-induced Th17 inflammation response in murine allergic asthma.
    Wang G; Pang Z; Chen-Yu Hsu A; Guan X; Ran N; Yuan Y; Wang Z; Guo Y; Zheng R; Wang F
    Eur J Pharmacol; 2019 Nov; 862():172623. PubMed ID: 31445014
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Structure of nucleosome-bound DNA methyltransferases DNMT3A and DNMT3B.
    Xu TH; Liu M; Zhou XE; Liang G; Zhao G; Xu HE; Melcher K; Jones PA
    Nature; 2020 Oct; 586(7827):151-155. PubMed ID: 32968275
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Structural insights into the activation of GLP-1R by a small molecule agonist.
    Ma H; Huang W; Wang X; Zhao L; Jiang Y; Liu F; Guo W; Sun X; Zhong W; Yuan D; Xu HE
    Cell Res; 2020 Dec; 30(12):1140-1142. PubMed ID: 32724086
    [No Abstract]   [Full Text] [Related]  

  • 99. Cryo-EM Structure of the Human Cannabinoid Receptor CB2-G
    Xing C; Zhuang Y; Xu TH; Feng Z; Zhou XE; Chen M; Wang L; Meng X; Xue Y; Wang J; Liu H; McGuire TF; Zhao G; Melcher K; Zhang C; Xu HE; Xie XQ
    Cell; 2020 Feb; 180(4):645-654.e13. PubMed ID: 32004460
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Glucocorticoids increase adiposity by stimulating Krüppel-like factor 9 expression in macrophages.
    Zhang Y; Du C; Wang W; Qiao W; Li Y; Zhang Y; Sheng S; Zhou X; Zhang L; Fan H; Yu Y; Chen Y; Liao Y; Chen S; Chang Y
    Nat Commun; 2024 Feb; 15(1):1190. PubMed ID: 38331933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.